Clinical Trials
Merck and Abbisko Report Positive Phase III Results for Pimicotinib in TGCT Across Asia, Europe, and North America
Phase III MANEUVER study met primary endpoint, with an objective response rate at week 25 of 54.0% for pimicotinib versus 3.2% for placebo (p<0.0001) ...
November 21, 2024 | News
Epigenic Therapeutics Secures Approval in New Zealand for World’s First Epigenetic Therapy Clinical Trial for Chronic Hepatitis B
Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy, announced that it has received appr...
November 20, 2024 | News
Everest Medicines' NEFECON® Gains Full Approval in South Korea for IgA Nephropathy Treatment
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
November 19, 2024 | News
Acepodia Secures FDA IND Clearance for ACE1831, Pioneering Gamma Delta T Cell Therapy in Autoimmune Disease
IND clearance paves the way for Acepodia to enter the clinic for the first time with its autoimmune program ACE1831 is an allogeneic gamma delta T...
November 18, 2024 | News
Ascentage Pharma’s Lisaftoclax NDA Accepted for Priority Review in China: A Potential First for Bcl-2 Inhibitors
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unm...
November 18, 2024 | News
Medidata and Bioforum Expand Partnership to Enhance AI-Driven Clinical Trials for Biotech Clients
-Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions for the life sciences industry announced a new corporate agr...
November 18, 2024 | News
Mabwell's Nectin-4 Targeting ADC Secures IND Approval for Clinical Trials in Perioperative Urothelial Carcinoma and Advanced Solid Tumors
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its novel Nectin-4 targeting ADC (R&D code: 9MW...
November 15, 2024 | News
Perth’s Lixa Kicks Off Clinical Trial for NeoX-101, Aiming to Combat Chronic Lung Infections
Lixa, a Perth-based biotechnology company, has announced the launch of its first clinical trial to evaluate the safety and tolerability of NeoX-101, an inn...
November 14, 2024 | News
Nxera Pharma Secures $3.5M Milestone as Centessa Pharmaceuticals Launches Phase 2 Trial of ORX750 for Sleep Disorders
Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – notes t...
November 14, 2024 | News
Transgene and NEC Unveil Positive 24-Month Data for TG4050 Cancer Vaccine in Adjuvant Treatment of Head and Neck Cancer at SITC 2024
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Cor...
November 14, 2024 | News
Taiwan's Caliway Biopharmaceuticals Receives EMA Orphan Drug Designation for CBL-514 in Dercum’s Disease Treatment
CBL-514 is the first and only drug to receive EMA Orphan Drug Designation for Dercum's disease treatment.- CBL-514 received both FDA Orphan Drug...
November 14, 2024 | News
Ascletis Completes Enrollment for Phase III Trial of ASC40 in Acne
Phase III trial enrolled a total of 480 patients with moderate to severe acne-Topline results expected in the second quarter 2025 Ascletis Pharma Inc. ann...
November 13, 2024 | News
Alphamab Oncology’s JSKN033 Receives Fast-Track Approval from Shanghai Drug Authority for Innovative Cancer Therapy Clinical Trials
Alphamab Oncology (stock code: 9966.HK) announced that a clinical trial (Study ID: JSKN033-102) of JSKN033, a high-concentration subcutaneous co-formulatio...
November 13, 2024 | News
Nordic Bioscience Secures FDA Letter of Support for CPa9-HNE Biomarker in Advancing IBD Clinical Trials
Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE biomarker assay received a Letter of Support (LoS) from the U.S. Food and Drug ...
November 12, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
